本文選題：TLR4 + MD2��； 參考：《寧夏醫(yī)科大學(xué)》2012年碩士論文

【摘要】：目的采用基因工程和分子生物學(xué)的方法，構(gòu)建體外表達(dá)Toll樣受體及與熱原反應(yīng)相關(guān)基因的細(xì)胞學(xué)模型，為檢測注射劑的熱原反應(yīng)提供實(shí)驗(yàn)室使用工具。 方法克隆人Toll樣受體4（TLR4）和髓樣分化蛋白（MD2），構(gòu)建pcDNA.3.1/myc-His(-)B-TLR4、pcDNA.3.1/myc-His(-)B-MD2真核表達(dá)載體。 ①pMD19-T-TLR4、pMD19-T-MD2克隆載體的構(gòu)建及鑒定：提取人外周血單核細(xì)胞總RNA，利用RT-PCR得到TLR4-1、TLR4-2和MD2的DNA�；厥誔CR產(chǎn)物連接于pMD-19T載體上進(jìn)行克隆和測序。②pcDNA.3.1/myc-His(-)B-TLR4表達(dá)載體的構(gòu)建及鑒定：測序鑒定后的pMD19-T-TLR4-2載體質(zhì)粒與pcDNA.3.1/myc-His(-)B表達(dá)載體質(zhì)粒同時進(jìn)行EcoRI和XhoI雙酶切，經(jīng)連接酶作用后，轉(zhuǎn)化至感受態(tài)E.coliTop10，氨芐青霉素篩選，挑取陽性克隆并酶切鑒定，得pcDNA.3.1/myc-His(-)B-TLR4-2載體質(zhì)粒。鑒定合格的pcDNA.3.1/myc-His(-)B-TLR4-2載體質(zhì)粒與pMD19-T-TLR4-1載體質(zhì)粒同時進(jìn)行hpaI和BamHI雙酶切，經(jīng)連接酶作用后，轉(zhuǎn)化至感受態(tài)E.coliTop10，氨芐青霉素篩選，挑取陽性克隆并酶切鑒定，最終獲得pcDNA.3.1/myc-His(-)B-TLR4載體質(zhì)粒。③pcDNA.3.1/myc-His(-)B-MD2表達(dá)載體的構(gòu)建及鑒定：pMD19-T-MD2載體質(zhì)粒與pcDNA.3.1/myc-His(-)B載體質(zhì)粒均以KpnI和XhoI分步雙酶切，經(jīng)連接酶作用后，，轉(zhuǎn)化至感受態(tài)E.coliTop10，氨芐青霉素篩選，挑取陽性克隆并酶切鑒定，得pcDNA.3.1/myc-His(-)B-MD2載體質(zhì)粒。④將pcDNA.3.1/myc-His(-)B-TLR4-1和pcDNA.3.1/myc-His(-)B-MD2通過電穿孔轉(zhuǎn)染法轉(zhuǎn)入HEK293細(xì)胞，在mRNA水平觀察TLR4及MD2基因的表達(dá)。 結(jié)果①利用RT-PCR成功獲得人TLR4-1、TLR4-2及MD2的cDNA，構(gòu)建pMD-19T-TLR4-1、pMD-19T-TLR4-2和pMD-19T-MD2質(zhì)粒載體經(jīng)酶切鑒定、測序及BLAST分析，得到重組質(zhì)粒。②構(gòu)建pcDNA.3.1/myc-His(-)B-TLR4和pcDNA.3.1/myc-His(-)B-MD2質(zhì)粒載體經(jīng)酶切鑒定、測序及BLAST分析，得到重組表達(dá)載體。③通過電穿孔轉(zhuǎn)染法，將pcDNA.3.1/myc-His(-)B-TLR4-1和pcDNA.3.1/myc-His(-)B-MD2轉(zhuǎn)染HEK293細(xì)胞后，在mRNA水平證明： TLR4和MD2基因有表達(dá)。 結(jié)論成功構(gòu)建表達(dá)Toll樣受體及與部分熱原反應(yīng)相關(guān)基因的表達(dá)載體，即人TLR4和MD2基因的真核表達(dá)載體pcDNA.3.1/myc-His(-)B-TLR4和pcDNA.3.1/myc-His(-)B-MD2，為構(gòu)建人TLR4及MD2基因敲入細(xì)胞學(xué)模型做前期準(zhǔn)備。
[Abstract]:Objective to construct a cytological model for expressing Toll like receptors and genes related to pyrogen reaction in vitro by genetic engineering and molecular biology, and to provide a laboratory tool for detecting the pyrogen reaction of injection.
Methods human Toll like receptor 4 (TLR4) and myeloid differentiation protein (MD2) were cloned, and pcDNA.3.1/myc-His (-) B-TLR4, pcDNA.3.1/myc-His (-) B-MD2 eukaryotic expression vector was constructed.
(1) construction and identification of pMD19-T-TLR4, pMD19-T-MD2 cloning vector: extracting the total RNA of human peripheral blood mononuclear cells, using RT-PCR to obtain TLR4-1, TLR4-2 and MD2 DNA. recovery PCR products to be cloned and sequenced on pMD-19T vector. Vector plasmids and pcDNA.3.1/myc-His (-) B expression vector plasmids were used for both EcoRI and XhoI double enzyme digestion. After the ligase action, the plasmid was converted to the receptive E.coliTop10, ampicillin was screened, the positive clones were selected and the enzyme was identified, and pcDNA.3.1/myc-His (-) B-TLR4-2 loaded particles were obtained. The qualified pcDNA.3.1/myc-His (-) B-TLR4-2 vector plasmid and P were identified. MD19-T-TLR4-1 vector plasmids were simultaneously digested with hpaI and BamHI. After the ligase action, the plasmid was transformed into the receptive E.coliTop10, ampicillin screening, the positive clones were selected and the enzyme was identified, and the pcDNA.3.1/myc-His (-) B-TLR4 vector plasmid was finally obtained. (3) the construction and identification of pcDNA.3.1/myc-His (-) B-MD2 expression vector: pMD19-T-MD2 carrying constitution The plasmid and pcDNA.3.1/myc-His (-) B vector were cut by KpnI and XhoI. After the ligase action, the plasmid was transformed to the receptive E.coliTop10, ampicillin was screened, the positive clones were selected and the pcDNA.3.1/myc-His (-) B-MD2 carrier plasmid was identified. (4) pcDNA.3.1/ myc-His (-) B-TLR4-1 and pcDNA.3.1/myc-His (-) B-MD2 through electroporation. The transfection method was transferred to HEK293 cells, and the expression of TLR4 and MD2 genes were observed at mRNA level.
Results (1) TLR4-1, TLR4-2 and MD2 cDNA were successfully obtained by RT-PCR, pMD-19T-TLR4-1, pMD-19T-TLR4-2 and pMD-19T-MD2 plasmid vectors were identified by enzyme digestion, sequencing and BLAST analysis, and recombinant plasmids were obtained. 2. Construction of pcDNA.3.1/myc-His (-) B-TLR4 and pcDNA.3.1/myc-His (-) plasmid vectors were identified by enzyme digestion, sequencing and analysis. Recombinant expression vector. (3) transfection of pcDNA.3.1/myc-His (-) B-TLR4-1 and pcDNA.3.1/myc-His (-) B-MD2 into HEK293 cells by electroporation transfection. The expression of TLR4 and MD2 genes was demonstrated at the mRNA level.
Conclusion the expression vector expressing Toll like receptor and the gene related to partial pyrogen reaction was successfully constructed, that is, the eukaryotic expression vector of human TLR4 and MD2 gene pcDNA.3.1/myc-His (-) B-TLR4 and pcDNA.3.1/myc-His (-) B-MD2, preparation for the construction of human TLR4 and MD2 gene into the cytological model.

【學(xué)位授予單位】：寧夏醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2012
【分類號】：R346

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 謝金文;萬勇;余為一;;CD14分子的研究進(jìn)展[J];安徽農(nóng)學(xué)通報(bào);2006年04期

2 單亞;;細(xì)菌內(nèi)毒素定量檢查法的發(fā)展概況及方法簡介[J];安徽醫(yī)藥;2008年04期

3 張樂逸;張宇飛;嵇武;;Toll樣受體4的研究進(jìn)展和臨床意義[J];腸外與腸內(nèi)營養(yǎng);2009年02期

4 陳永華,李昌麟,王韻,蔣建新,朱佩芳,張宗梁;核糖核酸酶保護(hù)法MD-2探針的制備[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2003年20期

5 楊清武,牟玲,朱佩芳,王正國,蔣建新,王景周;Toll樣受體4胞外區(qū)在畢赤酵母系統(tǒng)的初步表達(dá)及鑒定[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2005年01期

6 劉亞偉;劉靖華;唐靖;趙清;李建軍;趙明哲;李志杰;王國軍;鐘田雨;鄧鵬;姜勇;;用FRET技術(shù)研究TLR4和MD-2的相互作用[J];南方醫(yī)科大學(xué)學(xué)報(bào);2006年08期

7 李增宏;王瑞東;;發(fā)熱信號傳導(dǎo)途徑及診斷程序研究[J];佛山科學(xué)技術(shù)學(xué)院學(xué)報(bào)(自然科學(xué)版);2007年03期

8 劉興,馮文莉,康格非;脂多糖受體的研究進(jìn)展[J];國外醫(yī)學(xué).臨床生物化學(xué)與檢驗(yàn)學(xué)分冊;2001年03期

9 熊健;譚燕;吳曉鳳;劉華渝;趙玉峰;沈岳;李磊;;纖連蛋白對人外周血單核細(xì)胞TLR4介導(dǎo)的脂多糖反應(yīng)的影響[J];解放軍醫(yī)學(xué)雜志;2011年12期

10 鐘田雨;劉靖華;姜勇;;髓樣分化蛋白-2在識別和轉(zhuǎn)導(dǎo)內(nèi)毒素信號中的作用[J];生物化學(xué)與生物物理進(jìn)展;2007年05期

本文編號：1847956